Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jinglian Luo"'
Autor:
Xuhui Deng, Deyan Kong, Jian Tang, Yiju Xie, Jian Zhang, Shijian Chen, Zhijian Liang, Jinglian Luo, Yueling Zhang, Shengliang Shi
Publikováno v:
Journal of NeuroInterventional Surgery. 14:321-325
ObjectiveIn this review and meta-analysis we sought to compare the efficacy and safety of direct endovascular thrombectomy (EVT) and bridging therapy for intravenous thrombolysis (IVT)-eligible patients with acute ischemic stroke caused by large vess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33311c276f6f1e965fadc740e3f9e3c1
https://doi.org/10.1136/neurintsurg-2021-017928
https://doi.org/10.1136/neurintsurg-2021-017928
Autor:
Gang Zhong, Yueling Zhang, Huiping Long, Jian Zhang, Shengliang Shi, Chengzhi Wang, Jinglian Luo
Publikováno v:
Neurochemical Research. 44:1830-1839
The pathogenesis of late-onset Alzheimer's disease (LOAD) mainly involves abnormal accumulation of extracellular β-amyloid (Aβ) and the consequent neurotoxic effects. The triggering receptor expressed on myeloid cells 2 (TREM2) gene is associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e76731f9fc4e480c573f8bf8e2267ee
https://doi.org/10.1007/s11064-019-02817-1
https://doi.org/10.1007/s11064-019-02817-1
Publikováno v:
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the efficacy, safety, and tolerability of ozanimod for people with RRMS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d153ca5aa06082b80b7974ba53f39e
https://europepmc.org/articles/PMC9022725/
https://europepmc.org/articles/PMC9022725/
Autor:
Jian Zhang, Shijian Chen, Shengliang Shi, Yueling Zhang, Deyan Kong, Yiju Xie, Xuhui Deng, Jian Tang, Jinglian Luo, Zhijian Liang
Publikováno v:
Journal of NeuroInterventional Surgery; Apr2022, Vol. 14 Issue 4, p321-325, 6p
Autor:
Jian Tang, Deyan Kong, Shengliang Shi, Yujia Mei, Jinglian Luo, Jinyu Liang, Jianfeng Zhang, Renhong He, Jiefeng Luo, Jian Zhang, Yueling Zhang
Publikováno v:
SSRN Electronic Journal.
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system (CNS). The treatment of MS has always been a focus of neurological research. To date, the US Food and Drug Administration (FDA) has approved 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b18e81452d491a01b548a45e9839cf42
https://doi.org/10.2139/ssrn.3266988
https://doi.org/10.2139/ssrn.3266988
Autor:
Jian Zhang, Gang Zhong, Shengliang Shi, Chengzhi Wang, Yueling Zhang, Huiping Long, Jinglian Luo
Publikováno v:
Neurochemical Research. 44:1840-1840
The article titled "TREM2 Attenuates Aβ1‑42‑Mediated Neuroinflammation in BV‑2 Cells by Downregulating TLR Signaling", written by Huiping Long, Gang Zhong, Chengzhi Wang, Jian Zhang, Yueling Zhang, Jinglian Luo, Shengliang Shi, was originally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0a2aeb41e496a1dcee5618e2adab382
https://doi.org/10.1007/s11064-019-02828-y
https://doi.org/10.1007/s11064-019-02828-y